Key Details
Price
$13.01PE Ratio
32.53Annual ROE
-18.22%Beta
1.11Events Calendar
Next earnings date:
Feb 26, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Feb 26, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, NY / ACCESSWIRE / November 30, 2024 / If you experienced a loss from your investment in Elanco Animal Health Incorporated (NYSE:ELAN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=114173&wire=1 or reach out to Joseph E. Levi, Esq.
On November 30, 2024, a federal lawsuit was submitted to the U.S. District Court of Maryland against Elanco Animal Health Inc. and certain executives. They are accused of providing false and misleading information from November 7, 2023, to June 26, 2024.
LOS ANGELES, CA / ACCESSWIRE / November 30, 2024 / The Schall Law Firm, a national firm focused on shareholder rights, is reminding investors about a class action lawsuit against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). This lawsuit claims that the company violated certain sections of the Securities Exchange Act of 1934 and related rules. Investors who bought the company's securities between November 7, 2023, and June 26, 2024, are urged to reach out to the firm before December 6, 2024.
NEW YORK, Nov. 30, 2024 /PRNewswire/ -- The Rosen Law Firm, a worldwide law firm focused on investor rights, is reminding buyers of Elanco Animal Health Incorporated (NYSE: ELAN) securities from November 7, 2023, to June 26, 2024, about the crucial lead plaintiff deadline on December 6, 2024. If you bought Elanco securities during this time, you might be eligible for compensation without having to pay any upfront fees or costs, thanks to a contingency fee agreement.
On November 30, 2024, Bleichmar Fonti & Auld LLP, a prominent securities law firm, announced that a lawsuit has been initiated against Elanco Animal Health Incorporated and some of its top executives for possible breaches of federal securities laws. If you have invested in Elanco, you are invited to find more details by visiting their website.
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=114149&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES , Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE: ELAN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 7, 2023 and June 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 6, 2024.
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=114042&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=114033&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / November 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elanco securities between November 7, 2023, and June 26, 2024, inclusive (the "Class Period").
FAQ
- What is the primary business of Elanco Animal Health Incorporated?
- What is the ticker symbol for Elanco Animal Health Incorporated?
- Does Elanco Animal Health Incorporated pay dividends?
- What sector is Elanco Animal Health Incorporated in?
- What industry is Elanco Animal Health Incorporated in?
- What country is Elanco Animal Health Incorporated based in?
- When did Elanco Animal Health Incorporated go public?
- Is Elanco Animal Health Incorporated in the S&P 500?
- Is Elanco Animal Health Incorporated in the NASDAQ 100?
- Is Elanco Animal Health Incorporated in the Dow Jones?
- When was Elanco Animal Health Incorporated's last earnings report?
- When does Elanco Animal Health Incorporated report earnings?
- Should I buy Elanco Animal Health Incorporated stock now?